Carson Wealth (CWM LLC)
WHWK

Carson Wealth (CWM LLC)’s Whitehawk Therapeutics WHWK Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio WHWK Stock Details WHWK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$86 Hold
25
– – ﹤0.01% 5586
2025
Q4 		$0 Hold
25
– – ﹤0.01% 5724
2025
Q3 		$0 Hold
25
– – ﹤0.01% 5631
2025
Q2 		$0 Hold
25
– – ﹤0.01% 5363
2025
Q1 		$0 Hold
25
– – ﹤0.01% 5252
2024
Q4 		$0 Hold
25
– – ﹤0.01% 5230
2024
Q3 		$0 Sell
25
-136
-84% -$220 ﹤0.01% 5228
2024
Q2 		$0 Buy
161
+136
+544% +$252 ﹤0.01% 5006
2024
Q1 		$0 Hold
25
– – ﹤0.01% 4814
2023
Q4 		$0 Sell
25
-53
-68% -$222 ﹤0.01% 4578
2023
Q3 		$0 Buy
+78
New +$453 ﹤0.01% 4577

Other funds holding WHWK

QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
KCA
KVP Capital Advisors San Francisco, California $134M AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Carson Wealth (CWM LLC)'s WHWK Position: Q1 2026 in Review

Carson Wealth (CWM LLC) held its Whitehawk Therapeutics (WHWK) position steady in Q1 2026 at 25 shares worth $86. The position accounts for ﹤0.01% of the portfolio, ranked #5586.

Carson Wealth (CWM LLC) first reported a position in WHWK in Q3 2023 and has held it in 11 quarters since. 62 funds tracked by Wall St. Rank hold WHWK as of Q1 2026.

  • Carson Wealth (CWM LLC) held 25 shares of Whitehawk Therapeutics worth $86 as of Q1 2026.
  • Carson Wealth (CWM LLC) left its Whitehawk Therapeutics share count unchanged in Q1 2026.
  • Whitehawk Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5586 holding.
  • Carson Wealth (CWM LLC) first reported a position in Whitehawk Therapeutics in Q3 2023 and has held it in 11 quarters since.
  • 62 funds tracked by Wall St. Rank held Whitehawk Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.